Is the Monocyte Activation Test a Viable Alternative to Traditional Tests?

An article by Pyrodex Testing founder and principal Djik Maouyo was published in January by the PDA Letter, the magazine of the Parenteral Drug Association.

Current Perspectives on the Monocyte Activation Test

Is the Monocyte Activation Test a Viable Alternative to Traditional Tests?

In recent months, the market for the monocyte activation test (MAT) has grown. Many factors have spurred this growth, notably the potential for greater restrictions on animal testing. Yet as the test is relatively new in comparison to the traditional rabbit pyrogen test, concerns about its effectiveness remain.

PDA membership is required to read the entire article here.